Trial misconduct halts Evotec/Hyperion drug
September 10, 2014Research and Development, Sales and Marketing DiaPep277, Evotec, amdromeda, diabetes, hyperion
Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …
Liberation appoints account co-ordinator
September 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Mullin, Liberation, communications
UK-based healthcare comms agency Liberation has hired a new starter to its team with the appointment of Edward Mullin as …
Federal Trade Commission sues AbbVie and Teva
September 9, 2014Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission
Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …
‘Pocket doctor’ on the horizon for Parkinson’s
September 9, 2014Medical Communications, Sales and Marketing Nonlinearity and Complexity Research Group, Parkinson's, aston, dr little, pocket doctor
Smartphones will soon be able to perform the functions of a ‘pocket doctor’ and map Parkinson’s disease and other degenerative …
Celgene rebuffed by NICE over cancer drug
September 9, 2014Sales and Marketing Abraxane, Cancer, Celgene, Gemzar, NICE, gemcitabine, nab-paclitaxel
In new draft guidance NICE says that Celgene’s Abraxane (nab-paclitaxel) taken with Lilly’s Gemzar (gemcitabine) should not be funded by …
New chief executive and chairman for Evaluate
September 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing alex karle, evaluate
Life science market intelligence firm Evaluate has appointed Alex Karle to the role of chief executive, replacing the firm’s founder Dr …
New chief executive for ReNeuron
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Olav Hellebø, ReNeuron, clavis
UK-based stem cell therapy firm ReNeuron has appointed Olav Hellebø to be its new chief executive. Since starting his pharma …
NHS cancer services not holding up, says report
September 8, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology
NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …
Servier slammed over UK trial transparency failure
September 8, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials
Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …
BMS sues Merck over new melanoma drug
September 8, 2014Research and Development, Sales and Marketing BMS, FDA, Merck, PD-1 inhibitors, Yervoy, keytruda
Things are getting ugly between Bristol-Myers Squibb and Merck as the former company began legal proceedings against the latter over …
MHRA leads social media drug safety initiative
September 8, 2014Medical Communications, Sales and Marketing EFPIA, EU, MHRA, social media, web-radr
The MHRA has announced that it is to lead European medicines regulators, academics and pharma in a three-year project to …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
Theraclion hires chief executive and VP
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anja Kleber, David Caumartin, Theraclion
French medical device firm Theraclion has appointed David Caumartin as its chief executive and Anja Kleber as vice president of …
Sanofi releases new diabetes app for children
September 5, 2014Medical Communications, Sales and Marketing Gamification, Lilly board game, Sanofi, Syrum, monster manor
Sanofi Diabetes has launched a new mobile game aimed at educating children, teachers, parents and carers about living with type …
Remembering the patient in the Cancer Drugs Fund debate
September 5, 2014Medical Communications, Sales and Marketing Beating Bowel Cancer, Cancer Drugs Fund, Kadclya, Roche
Today Simon is a bowel cancer patient who is able to enjoy his weekly round of golf.After receiving the dreadful …
Edelman buys Elan to ‘challenge’ the French PR industry
September 5, 2014Medical Communications, Sales and Marketing Edelman, Elan, publicis
Edelman has swooped in on fellow PR firm Elan to create a ‘new player’ in the communications industry in France. …
NHS spends over £1 million on Apple products
September 5, 2014Medical Communications, Sales and Marketing Apple, NHS England, ipad, iphone
NHS England has spent more than £1.2 million on Apple’s tablets and smartphones since it was set up two years’ …
Merck surprise winner in PD-1 race
September 5, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1
Merck has become the first company to bring a new class of cancer drug to the US market after the …
J&J fast-track Ebola vaccine for early 2015 trials
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, Mapp, zmapp
Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly …
Teva launches new MS eHealth site
September 4, 2014Medical Communications, Sales and Marketing Teva, digital, ms ireland, multiple sclerosis, pow health
Teva and MS Ireland have helped launch a new website called Pow Health to give multiple sclerosis patients a “one-stop …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
